Project Grant K01CA282211

Award Date 6/14/24
Completion Date 5/31/29
Dollars Obligated $130K
Federal Grant Program
93.398
Assistance Type
Project Grant
Place of Performance
West Lafayette, IN 47907, USA
Similar Awards
The Project Grant award R21CA287170 for $395,051 from the National Cancer Institute's (NCI) Cancer Cause and Prevention Research program (CFDA 93.393) is funding a study by Rutgers, The State University of New Jersey to evaluate the implementation and impact of a new state law in New Jersey that requires tobacco retailers to sell nicotine replacement therapy (NRT). The study will use a mixed methods approach to: 1) determine if NRT compliance varies by neighborhood characteristics, and 2)...
This Project Grant award for $188,913, provided by the National Institutes of Health (NIH) Office of the Director under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077), aims to develop and assess educational messages about the continuum of nicotine product risk among socioeconomically disadvantaged adult smokers. The key objectives are to: 1) qualitatively assess risk perceptions of nicotine products among low-SES smokers, 2) design and test...
This Project Grant award from the National Cancer Institute (NCI), under the Cancer Cause and Prevention Research federal grant program (CFDA 93.393), supports research to investigate tobacco use behaviors and related mechanisms among U.S. adults and youth representing minority and intersecting minority identities. The total award amount is $226,504, spanning the period from April 11, 2025 to March 31, 2027. The primary awardee is George Washington University, which will utilize the funding to...
This federal Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) provides $675,599 in funding to Rutgers, The State University of New Jersey, to study the implementation, reach, and impact of court-ordered tobacco corrective statement postings at the point-of-sale. The 12-month project, beginning September 1, 2024, aims to characterize the implementation and reach of the court-ordered signage,...
The National Cancer Institute (NCI) awarded a $515,632 Project Grant under the Cancer Cause and Prevention Research (CFDA 93.393) program to the Regents of the University of Minnesota. The 3-year grant, starting on May 2, 2025, aims to ensure the U.S. is prepared to maximize smoking cessation during and following the implementation of proposed cigarette product standards by the FDA. The project will: 1) Estimate, for each U.S. state, the number and fold increase of people who smoke (PWS) who...
This $622,957 Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077) supports research at Duke University to investigate the impact of novel tobacco product designs and synthetic additives on use initiation and preference behavior. The key research objectives are to: 1) analyze the chemical composition of oral nicotine pouches and "non-menthol"...
This $885,824 federal Project Grant award from the National Cancer Institute's Cancer Cause and Prevention Research program (CFDA 93.393) supports a research project conducted by Health Research, Inc. at its Roswell Park Division in Buffalo, New York. The project aims to explore consumer responses to the recent FDA authorizations allowing certain smokeless tobacco products to make modified risk claims in their marketing. The research activities include an online survey and experiment, an...
This federal Project Grant award from the National Institute on Minority Health and Health Disparities (NIMHD), part of the National Institutes of Health (NIH), under the Minority Health and Health Disparities Research program (CFDA 93.307), provides $694,771 to evaluate population-based strategies for improving smoking cessation among rural residents. The key activities under this 5-year project include: 1) Conducting a randomized controlled trial to determine if providing rural people who...
This Project Grant award from the National Cancer Institute (NCI), under the federal Cancer Cause and Prevention Research program (CFDA 93.393), seeks to enhance the reach and effectiveness of tobacco cessation treatment for socioeconomically disadvantaged individuals who smoke. The $667,828 award to Case Western Reserve University will fund the adaptation, implementation, and sustainability evaluation of a community-based "Ask-Advise-Connect" (CA-AAC) model within food pantry...
This Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) will support research to investigate social network influences on youth nicotine product use transitions, including combustible cigarettes and e-cigarettes, and to evaluate the effectiveness of different intervention strategies. The $557,312 award will fund a 5-year study to gather data from a cohort of Mexican high school students, measure their friendship and online interaction...

This federal Project Grant award of $129,708 from the National Cancer Institute's Cancer Research Manpower program (CFDA 93.398) supports research to examine the impact of local tobacco retail policies on sociodemographic disparities in tobacco use outcomes. The principal investigator will use advanced statistical methods to: 1) assess the impact of tobacco retailer licensing laws and fees on retailer density differences by race/ethnicity, income, and education; 2) measure the impact of local restrictions on flavored tobacco product sales on sociodemographic differences in product sales; and 3) investigate the interactive effect of both policies on individual-level exclusive and dual use of cigarettes and e-cigarettes among youth and adults. This 5-year project, awarded on June 14, 2024, will help policymakers understand how to revise existing or adopt new retail policies to address tobacco use disparities in local communities.

Generated 6/10/25, 5:49 AM